RENAISSANCE PHARMA Trademark

Trademark Overview


On Tuesday, October 2, 2012, a trademark application was filed for RENAISSANCE PHARMA with the United States Patent and Trademark Office. The USPTO has given the RENAISSANCE PHARMA trademark a serial number of 85743526. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 5, 2020. This trademark is owned by RENAISSANCE PHARMA INC.. The RENAISSANCE PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and devices, namely, Athletes' foot preparations; Bismuth preparations for pharmaceutical use; Pharmaceutical preparations for use in ocular disorders; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the relief of pain; Pharmaceutical preparations for the treatment of acne; Pharmaceutical preparations for the treatment of allergies; Pharmaceutical preparations for the treatment of bacterial skin infections, viral skin infections and parasitic skin infections; Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations for the treatment of carpal tunnel syndrome; Pharmaceutical preparations for the treatment of chronic pain; Pharmaceutical preparations for the treatment of dental and oral diseases; Pharmaceutical pr...
renaissance pharma

General Information


Serial Number85743526
Word MarkRENAISSANCE PHARMA
Filing DateTuesday, October 2, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 5, 2020
Registration Number4419742
Registration DateTuesday, October 15, 2013
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 26, 2013

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMA"
Description of MarkThe mark consists of the words "RENAISSANCE PHARMA" in stylized form with a representation of a butterfly situated to the upper right.
Goods and ServicesPharmaceutical products and devices, namely, Athletes' foot preparations; Bismuth preparations for pharmaceutical use; Pharmaceutical preparations for use in ocular disorders; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the relief of pain; Pharmaceutical preparations for the treatment of acne; Pharmaceutical preparations for the treatment of allergies; Pharmaceutical preparations for the treatment of bacterial skin infections, viral skin infections and parasitic skin infections; Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations for the treatment of carpal tunnel syndrome; Pharmaceutical preparations for the treatment of chronic pain; Pharmaceutical preparations for the treatment of dental and oral diseases; Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders; Pharmaceutical preparations for the treatment of diseases, disorders and infections of the spinal cord systems and related cartilage and tissue; Pharmaceutical preparations for the treatment of drug and alcohol abuse; Pharmaceutical preparations for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment of genitor-urinary and pelvic diseases, disorders and infections, namely, infertility, sexually transmitted diseases, incontinence and sexual dysfunction; Pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical preparations for the treatment of glaucoma; Pharmaceutical preparations for the treatment of headaches; Pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; Pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; Pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; Pharmaceutical preparations for the treatment of metabolic disorders, namely, diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; Pharmaceutical preparations for the treatment of migraine; Pharmaceutical preparations for the treatment of motion sickness; Pharmaceutical preparations for the treatment of myalgia and neuralgia; Pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; Pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; Pharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; Pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction; Pharmaceutical preparations for the treatment of psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis, seizures; Pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; Pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections; Pharmaceutical preparations for the treatment of skin irritations, namely, bee stings, sunburn, rashes, sores, corns, calluses, and acne; Pharmaceutical preparations for the treatment of smoking cessation; Pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system, infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; Pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; Pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system, namely, brain, movement, ocular motility and spinal cord diseases; Pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; Pharmaceutical preparations for the treatment of the respiratory system; Pharmaceutical preparations for the treatment of varicose veins; Pharmaceutical preparations for the treatment of vascular diseases; Pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); Pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; Pharmaceutical preparations for use in gastroenterology; Thyroid hormonal preparations; Vaginal antifungal preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 5, 2020
Primary Code005
First Use Anywhere DateSunday, July 1, 2012
First Use In Commerce DateMonday, July 1, 2013

Trademark Owner History


Party NameRENAISSANCE PHARMA INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLONGUEUIL J4H3Z6
CA

Party NameRENAISSANCE PHARMA INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLONGUEUIL J4H3Z6
CA

Party NameRENAISSANCE PHARMA INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLONGUEUIL J4H3Z6
CA

Trademark Events


Event DateEvent Description
Friday, June 5, 2020CANCELLED SEC. 8 (6-YR)
Monday, October 15, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 15, 2013REGISTERED-PRINCIPAL REGISTER
Saturday, September 7, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, September 6, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, September 6, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 30, 2013STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 4, 2013USE AMENDMENT FILED
Friday, July 26, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 4, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, May 21, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 26, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2013PUBLISHED FOR OPPOSITION
Wednesday, March 6, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 21, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, February 21, 2013ASSIGNED TO LIE
Wednesday, February 6, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 6, 2013EXAMINER'S AMENDMENT ENTERED
Wednesday, February 6, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 6, 2013EXAMINERS AMENDMENT E-MAILED
Wednesday, February 6, 2013EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 6, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 6, 2013NON-FINAL ACTION E-MAILED
Wednesday, February 6, 2013NON-FINAL ACTION WRITTEN
Wednesday, January 30, 2013ASSIGNED TO EXAMINER
Wednesday, October 10, 2012NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, October 9, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM